The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics.
作者信息
Schenker S, Hoyumpa A M, Wilkinson G R
出版信息
Med Clin North Am. 1975 Jul;59(4):887-96. doi: 10.1016/s0025-7125(16)31987-3.
PMID:238085
Abstract
摘要
相似文献
1
The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics.
Med Clin North Am. 1975 Jul;59(4):887-96. doi: 10.1016/s0025-7125(16)31987-3.
2
The disposition and effects of sedatives and analgesics in liver disease.
Annu Rev Med. 1978;29:205-18. doi: 10.1146/annurev.me.29.020178.001225.
3
Effects of liver disease and of aging on the disposition and elimination of sedatives.
Trans Am Clin Climatol Assoc. 1978;89:91-9.
4
Drug disposition and liver disease.
Drug Metab Rev. 1975;4(2):139-75. doi: 10.3109/03602537508993754.
5
Disposition and elimination of minor tranquilizers in the aged and in patients with liver disease.
South Med J. 1978 Aug;71 Suppl 2:23-8. doi: 10.1097/00007611-197808001-00006.
6
The influence of liver diseases on drug disposition.
Clin Gastroenterol. 1979 Jan;8(1):105-21.
7
[Hypnotics and sedatives in liver diseases (summary of session 4)].
Z Gastroenterol Verh. 1976(12):203-20.
8
[Clinical problems in the application of sedatives in patients with chronic liver disease (author's transl)].
Z Gastroenterol. 1977 Jun;15(6):356-61.
9
Impaired elimination of meperidine in patients with liver disease.
Trans Assoc Am Physicians. 1974;87:281-7.
10
The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
Crit Care Nurs Clin North Am. 2005 Sep;17(3):245-50. doi: 10.1016/j.ccell.2005.04.007.
引用本文的文献
1
Pharmacokinetics of drug overdose.
Clin Pharmacokinet. 1981 May-Jun;6(3):161-92. doi: 10.2165/00003088-198106030-00001.
2
Effects of hepatic function on vancomycin clinical pharmacology.
Antimicrob Agents Chemother. 1983 Apr;23(4):603-9. doi: 10.1128/AAC.23.4.603.
Zotero 插件